Tag Archive | "china"

BVCF raises $188 million in equity financing

Tags: , ,


BVCF closed $188 million in equity fundraising financing.   Read the full story

Bayer makes a m&a deal with Dihon

Tags: , , ,


Bayer enters into a m&a with China-based, Dihon Pharmaceutical for an undisclosed amount. Read the full story

China pharma, Zhejiang Hisun raised $328 million in financing

Tags: , , ,


Zhejiang Hisun Pharma will raise at least 2 billion RMB ($328 million) in a private placement financing. Read the full story

Cardinal Health plans $90 million in China acquisitions

Tags: , ,


Cardinal Health, the US-based drug distributor, plans to make $90 million in China acquisitions to bolster its geographic coverage in mainland China. In addition, Cardinal said it is expanding its China product offerings to include medical products, lab equipment and other supplies. Read the full story

Lights are flashing green for biotech investment in China

Tags:


How can investors in the West take advantage of what is happening in the life science sector in China, and what are its implications for the future of US VC funding? A featured panel at Biotech Showcase™ 2012 sought some answers.  Read the full story

Drugmakers eye small cities

Tags: ,


BEIJING / SHANGHAI – As reform of China’s medical care system makes its way down to some of the smaller cities in China, multinational pharmaceutical companies are turning their eyes to those places, while they may face challenges and uncertainties, analysts said.  Read the full story

Pfizer plots JV with China’s Hisun Pharma

Tags: , , , , ,


Pfizer has agreed to team with a Chinese drugmaker on branded generics… Read the full story

Bigpharma increases activity in China

Tags: , , , , , , , , , , , , ,


The start of 2011 has seen some significant deal activity involving Bigpharma in China. Read the full story

SciClone strikes $105m deal to buy China’s NovaMed

Tags: ,


Lured by the booming Chinese pharmaceuticals market, Foster City, CA-based SciClone Pharmaceuticals ($SCLN) has struck a deal to buy Shanghai-based NovaMed Pharmaceuticals for $24.7 million in cash and $37.1 million in stock. Read the full story

Pfizer and Daiichi Sankyo team up in China

Tags: , , , ,


Pfizer has agreed to promote a hypertension drug from Daiichi Sankyo Pharma in China.  Read the full story

cp300x1502gif
2014pharmaci-usabanner300x150gif
current-partnering-300x150jpg
RSS Feed Linked In Twitter

Latest Tweets

cp300x1502gif
bpa14banner300x150jpg
beu14banner300x150jpg